cbdMD, Inc. YCBD released its first quarter of fiscal 2023 results, revealing net sales of $6.1 million, a decrease of 22% compared to net sales of $7.8 million in the Q4 2022, and a decrease of 35% compared to $9.3 million in the Q1 2022.
Q1 2023 Financial Highlights
-
Gross profit was $3.6 million compared to $5 million in Q1 2022.
-
Gross profit margin was 59% versus 54% for the prior year period.
-
Net loss improved to $3.9 million on sales of $6.1 million as compared to a $19.1 million net loss on sales of $9.3 million in the prior year comparative quarter.
-
Loss from operations of approximately $4.0 million for the quarter ending December 31, 2022 compared to a $25.1 million loss from operations for our quarter ending December 31, 2021, a reduction of approximately $21 million or 84% year over year.
Other Highlights
-
The company launched cbdMD Max with patented Univestin that has clinical pain claims.
-
cbdMD Therapeutics completed our human clinical study and results indicated our proprietary broad spectrum reduces pain in healthy adults, in addition to other significant indications on mood, immunity and sleep. The data is currently being used to support product development and marketing campaigns.
-
Adara Acquisition Corporation completed its merger with Alliance Entertainment Inc. on February 10, 2023 and the company received back its $1 million investment in Adara Sponsor, LLC.
-
cbdMD entered into an agreement for advertising placement with a360 Media, LLC in which a360 will provide professional media support and advertising placement in exchange for shares of the company's common stock.
Benzinga's Cannabis Capital Conference Is Back
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.